Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
J Chem Phys ; 137(7): 074302, 2012 Aug 21.
Article in English | MEDLINE | ID: mdl-22920115

ABSTRACT

S-branch N(2)-H(2) Raman linewidths have been measured in the temperature region 294-1466 K using time-resolved dual-broadband picosecond pure rotational coherent anti-Stokes Raman spectroscopy (RCARS). Data are extracted by mapping the dephasing rates of the CARS signal temporal decay. The J-dependent coherence decays are detected in the time domain by following the individual spectral lines as a function of probe delay. The linewidth data set was employed in spectral fits of N(2) RCARS spectra recorded in binary mixtures of N(2) and H(2) at calibrated temperature conditions up to 661 K using a standard nanosecond RCARS setup. In this region, the set shows a deviation of less than 2% in comparison with thermocouples. The results provide useful knowledge for the applicability of N(2) CARS thermometry on the fuel-side of H(2) diffusion flames.

2.
IEEE Trans Haptics ; 2(3): 141-147, 2009.
Article in English | MEDLINE | ID: mdl-27788078

ABSTRACT

A driving simulator study was conducted to investigate whether interaction with an in-vehicle multifunctional interface maneuvered by a rotary control can be improved if assisting haptics is provided. Two conditions were compared in the study, one in which neutral haptics was provided through the rotary control and another in which enhanced haptics was provided. Participants drove on a curved rural road while performing tasks such as list scrolling, radio tuning, address and number entry, and sound settings adjustments. When enhanced haptics was provided, the radio tuning was faster and fewer glances to the display were required, and the sound settings adjustments were completed with a reduced duration of the glances. However, improvements are needed for the other tasks. Enhanced haptics seems to facilitate interaction with functions in which the sensations can be incorporated in an intuitive way.

3.
Respir Med ; 95(9): 744-52, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11575896

ABSTRACT

We wanted to test whether living environment, occupation and social position are risk factors for asthma and chronic bronchitis/emphysema (CBE). The prevalence of bronchial asthma, CBE, respiratory symptoms and smoking habits in a random sample of 12,071 adults aged 20-59 years was assessed in a postal survey with a slightly modified questionnaire previously used in central and northern Sweden (The OLIN studies). Occupation was coded according to a socio-economic classification system. Six different living environment areas were defined; city-countryside, seaside-not seaside and living close to heavy traffic-not living close to heavy traffic. Multiple logistic regression analysis (forward conditional) was applied to estimate the association between the proposed set of risk factors and self-reported obstructive lung diseases and lower respiratory symptoms controlling for age, gender and smoking. After two reminders, the response rate was 70.1% (n=8469); 33.8% of the responders were smokers. In all, 469 subjects (5.5%) stated that they had asthma and 4.6% reported CBE. Besides smoking, which was a risk for both asthma and CBE, there were different risk patterns for self-reported asthma and CBE. In the economically active population there was a tendency that CBE was more common among 'unskilled and semi-skilled workers'. This fact was further emphasized when the population was merged into the two groups 'low social position' and 'middle/high social position', with 'low social position' as a risk for CBE (OR=1.35, 95% CI=1.06-1.72). No social risk factors were identified for asthma. Living close to heavy traffic was a risk factor for asthma (OR=1.29, 95% CI=1.02-1.62) but not for CBE. Apart from this no living environmental risk factors for obstructive pulmonary diseases were identified. Asthma symptoms and long-standing cough were more common among those subjects living close to heavy traffic compared to those not living close to heavy traffic. To conclude, low social position was a risk factor for CBE and living close to heavy traffic was a risk factor for asthma.


Subject(s)
Lung Diseases, Obstructive/epidemiology , Social Class , Adult , Air Pollutants/adverse effects , Female , Humans , Logistic Models , Male , Middle Aged , Prevalence , Risk Factors , Rural Health , Smoking/epidemiology , Sweden/epidemiology , Urban Health
4.
Article in English | MEDLINE | ID: mdl-11223396

ABSTRACT

A simple and reproducible method for isolating oxyntic glands from the rat gastric mucosa was developed. The mucosa was incubated with pronase and EGTA, and then treated mechanically to release glands that were separated from single cells by sedimentation. Parietal cells were identified by immunostaining using a monoclonal antibody against H,K-ATPase. The glandular cells appeared morphologically intact. By careful control of the conditions of gland isolation, long glandular structures comprising hundreds of cells surrounding the lumen were obtained. Intraperitoneal injection of Br-deoxyuridine in the rat 1.5 h before the isolation procedure resulted in glands with a labeling of cells in their neck region. The glands were viable, as demonstrated by their ability to respond to various hormones. Histamine dose-dependently stimulated the acid formation which was measured as the accumulation of [14C]aminopyrine. At 100 microM histamine the accumulation was increased 5-10-fold. At 100 nM, pentagastrin potentiated the histamine stimulated accumulation by approximately 40% but pentagastrin alone did not stimulate. The oxyntic glands obtained by the present procedure appear useful for studies on cell physiology, including regulation of acid secretion, cellular interactions, and possibly also differentiation and proliferation mechanisms since long glandular fragments that contained the proliferative zone could be isolated.


Subject(s)
Parietal Cells, Gastric/cytology , Animals , Immunohistochemistry , Male , Rats
5.
Article in English | MEDLINE | ID: mdl-10908854

ABSTRACT

Isolated gastric glands and isolated cells prepared from rabbit and rat were studied to analyse the influence of cholecystokinin octapeptide (CCK 8) on histamine stimulated parietal cell acid formation as assessed by [14C]aminopyrine sequestered in acid tissue compartments. In rabbit gastric glands, CCK 8 evoked 32+/-6% (P<0. 01) inhibition of histamine stimulated acid formation, whereas in glands prepared from rat no inhibition was recorded. Instead, CCK 8 seemed to induce a variable increase of the histamine stimulation in rat gastric glands as the aminopyrine accumulation was increased by 110+/-46% (P<0.1). Further studies on cell preparations derived from rabbit gastric mucosa revealed dual properties of CCK 8, eliciting either inhibition or stimulation of the parietal cell depending on the presence of endocrine cells. The results show that paracrine communication may be effective in glandular preparations, but seems to vary depending on species.


Subject(s)
Cholecystokinin/metabolism , Gastric Acid/metabolism , Gastric Mucosa/metabolism , Aminopyrine/pharmacokinetics , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Cell Count , Cells, Cultured , Cholecystokinin/pharmacology , Dose-Response Relationship, Drug , Enteroendocrine Cells/cytology , Enteroendocrine Cells/metabolism , Gastric Mucosa/cytology , Gastric Mucosa/drug effects , Histamine/metabolism , Histamine/pharmacology , In Vitro Techniques , Parietal Cells, Gastric/cytology , Parietal Cells, Gastric/drug effects , Parietal Cells, Gastric/metabolism , Rabbits , Rats , Sincalide/metabolism , Sincalide/pharmacology , Somatostatin/metabolism , Somatostatin/pharmacology
6.
Opt Lett ; 25(20): 1535-7, 2000 Oct 15.
Article in English | MEDLINE | ID: mdl-18066270

ABSTRACT

A novel technique for coherent anti-Stokes Raman spectroscopy (CARS) measurements in multiple points is presented. With a system of cylindrical lenses, each laser beam is split into several focused beams, yielding separate planar boxcars configurations. Spectrally resolved CARS signals are detected at different heights on the CCD chip. With dual-broadband rotational CARS the setup is demonstrated for quantitative measurements of temperature- and oxygen-concentration profiles. The technique was demonstrated for three points only, but it can be extended to more points by use of special optics; this choice must be based on a sufficient signal-to-noise ratio in all points for the actual measurement condition.

7.
Appl Opt ; 39(21): 3683-90, 2000 Jul 20.
Article in English | MEDLINE | ID: mdl-18349943

ABSTRACT

Measurements of soot properties by means of laser-induced incandescence (LII) and combined scattering-extinction were performed in well-characterized premixed ethylene-air flames. In particular, the possibility of using LII as a tool for quantitative particle sizing was investigated. Particle sizes were evaluated from the temporal decay of the LII signal combined with heat balance modeling of laser-heated particles, and these sizes were compared with the particle sizes deduced from scattering-extinction measurements based on isotropic sphere theory. The correspondence was good early in the soot-formation process but less good at later stages, possibly because aggregation to clusters began to occur. A critical analysis has been made of how uncertainties in different parameters, both experimental and in the model, affect the evaluated particle sizes for LII. A sensitivity analysis of the LII model identified the ambient-flame temperature as a major source of uncertainty in the evaluated particle size, a conclusion that was supported by an analysis based on temporal LII profiles.

8.
Eur J Clin Pharmacol ; 55(4): 305-9, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10424324

ABSTRACT

OBJECTIVE: The antidiuretic effect of desmopressin is widely utilized in the treatment of neurogenic diabetes insipidus and nocturnal enuresis in children. The objective of the present study was to assess how changes in gastrointestinal motility, induced by erythromycin and loperamide, influence the pharmacokinetics of orally administered desmopressin. METHODS: This study was conducted using an open randomized, three-period, three-treatment design in 18 healthy subjects. On each study day a single oral dose of 400 microg desmopressin was administered in the morning. The desmopressin dose was either given alone (reference) or after pretreatment with either loperamide tablets (4 mg at -24, -12 h and -1 h) or erythromycin capsules (250 mg q.i.d, with the first dose in the morning 3 days before the study day and the last dose at -1 h). On each study day, blood was sampled up to 8 h after dosing for assessment of desmopressin concentration. RESULTS: Compared with administration of 400 microg of desmopressin alone, pretreatment with loperamide produced significantly (P < 0.05) altered pharmacokinetics of desmopressin as the endpoints; area under the curve up to infinity (AUC), area up to the last determinable plasma concentration (AUCt) and maximum plasma concentration (Cmax) increased 3.1-fold (95% CI 2.3-4.2), 3.2 (2.3-4.4) and 2.3 (1.6 3.2), respectively. Although the estimates were lower, pretreatment with erythromycin did not result in any significant changes in these endpoints. There were no significant changes observed between the three treatments regarding the terminal elimination half-life (t1/2). However, significant (P < 0.05) changes in the time to reach Cmax (tmax) values (median and range) were observed as, compared with administration of desmopressin alone (1.3 h and 0.5-4.0), it was longer after pretreatment with loperamide (2.0 h and 0.5-3.0) and shorter following pre-treatment with erythromycin (0.9 h and 0.5-1.3). CONCLUSION: Presumably due to slower gastrointestinal motility, pretreatment with loperamide significantly increases the gastrointestinal absorption of desmopressin. Except for a shortening of tmax pretreatment with erythromycin did not significantly influence absorption of the drug.


Subject(s)
Anti-Bacterial Agents/pharmacology , Deamino Arginine Vasopressin/pharmacokinetics , Erythromycin/pharmacology , Gastrointestinal Agents/pharmacology , Gastrointestinal Motility/drug effects , Intestinal Absorption/drug effects , Loperamide/pharmacology , Renal Agents/pharmacokinetics , Adult , Anti-Bacterial Agents/adverse effects , Deamino Arginine Vasopressin/adverse effects , Drug Interactions , Erythromycin/adverse effects , Female , Gastrointestinal Agents/adverse effects , Gastrointestinal Motility/physiology , Humans , Loperamide/adverse effects , Male , Middle Aged , Renal Agents/adverse effects
9.
BJU Int ; 83(6): 591-5, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10233563

ABSTRACT

OBJECTIVE: To evaluate the decrease in nocturnal diuresis, nocturnal polyuria and the safety of oral desmopressin in elderly subjects with nocturia. SUBJECTS AND METHODS: After being identified using a population-based questionnaire, subjects were included in the study if they; (i) were healthy and free from medication with possible influence on the diuresis or voiding pattern; (ii) had an increased nocturnal frequency (>/=2 nocturnal voids/night, as reported before screening); (iii) had a nocturnal urinary output of >/=0.9 mL/min; (iv) completed and responded to an initial dose-titration study. Twelve men and five women (mean age 67.7 years, sd 4.6 years) met these criteria and were treated with oral desmopressin or placebo at bedtime for 2 weeks on each medication in a randomized, double-blind, crossover design. RESULTS: Subjects treated with desmopressin had a significantly reduced nocturnal diuresis of 0.59 mL/min compared with those on placebo (95% confidence interval, CI, 0.33-0.85). The 24-h diuresis was unaffected by desmopressin treatment. Patients treated with desmopressin had fewer micturitions at night than had those on placebo (1.1 and 1.7, respectively; P<0.001; mean difference=0.59; 95% CI, 0.32-0.85). The reduction in nocturnal diuresis was dependent on the baseline level of night-time diuresis (r=0.886; r2=0.785; P<0.0001) and the nocturnal part of the baseline 24 h-diuresis (r=0.708; r2=0.502; P<0.001). After desmopressin treatment was withdrawn, diuresis returned to the levels before treatment. The time from falling asleep to first awakening was improved by 1.4 h in patients treated with desmopressin. There was no change in body weight or ankle circumference during desmopressin treatment. Overall, the treatment was well tolerated and no serious adverse events were observed. CONCLUSION: Desmopressin was effective in reducing nocturnal diuresis and nocturnal voids in polyuric elderly subjects, with no significant adverse events or inconvenience to the patient. The length of uninterrupted sleep was also improved.


Subject(s)
Deamino Arginine Vasopressin/administration & dosage , Polyuria/drug therapy , Renal Agents/administration & dosage , Administration, Oral , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged , Urination Disorders/drug therapy
10.
Br J Urol ; 82(5): 642-6, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9839577

ABSTRACT

OBJECTIVE: To evaluate the decrease in nocturnal polyuria and the tolerability of three different doses of oral desmopressin in elderly subjects. SUBJECTS AND METHODS: Subjects were included in the study if they; (i) were healthy and free from medication with possible influence on their diuresis or voiding pattern: (ii) had an increased nocturnal frequency (> or = 2 nocturnal voids, as reported in the pre-screening period); and (iii) had a nocturnal urinary output of > or = 0.9 mL/min. Seventeen men and six women (mean age 68.1, SD 4.7 years) met these criteria and were treated with 0.1, 0.2 and 0.4 mg oral desmopressin given at bedtime, each dose taken for one week on three consecutive weeks. RESULTS: The mean (SD) nocturnal diuresis before treatment was 1.6 (0.7) mL/min, which decreased significantly to 1.1 (0.4) mL/min when 0.1 mg desmopressin was given. A dose of 0.2 mg desmopressin resulted in a further small decrease in the nocturnal diuresis to 0.9 (0.4) mL/min, whereas the 0.4 mg dose produced no additional effect. The reduction in nocturnal diuresis occurred almost exclusively in the group with a nocturnal urinary output of > or =1.3 mL/min. After treatment, diuresis returned to pretreatment levels. There was no change in body weight or in ankle circumference during desmopressin treatment and no serious adverse effects were observed. CONCLUSION: Desmopressin reduces nocturnal diuresis in polyuric elderly subjects and this reduction, occurring with doses of 0.1 mg given at bedtime, does not increase in a dose-dependent way.


Subject(s)
Deamino Arginine Vasopressin/administration & dosage , Polyuria/drug therapy , Renal Agents/administration & dosage , Administration, Oral , Aged , Diuresis , Dose-Response Relationship, Drug , Female , Humans , Male , Middle Aged , Polyuria/physiopathology
11.
Appl Opt ; 37(36): 8392-6, 1998 Dec 20.
Article in English | MEDLINE | ID: mdl-18301664

ABSTRACT

A common experimental problem with rotational coherent anti-Stokes Raman spectroscopy (CARS) is undesired spectral interference that is due to stray light from the primary laser beams. Also, for the most developed approach, dual-broadband rotational CARS, practical measurements often suffer from stray light interference from the narrow-band laser, inasmuch as the CARS signal is produced inherently in the spectral vicinity of the narrow-band laser beam. An optical filter does not provide a sufficiently sharp transmission profile, thus leading to signal loss and spectral distortion of the rotational CARS signal. An atomic filter consisting of a sodium-seeded flame is presented here as a solution to the problem, and its usefulness was demonstrated in dual-broadband rotational CARS experiments.

12.
Acta Radiol ; 38(2): 338-9, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9093178

ABSTRACT

Two different teleradiology concepts are described. Their advantages, disadvantages and costs are discussed.


Subject(s)
Computer Communication Networks/economics , Computer Communication Networks/instrumentation , Teleradiology/economics , Teleradiology/methods , Humans
13.
J Telemed Telecare ; 2(3): 161-4, 1996.
Article in English | MEDLINE | ID: mdl-9375051

ABSTRACT

For the last four years there has been a videoconferencing link between the Karlskrona hospital and the university hospital of Lund. Because of a need to transmit angiographic films, its use has been gradually expanded to become an everyday routine, used for both elective and emergency examinations. During 1994 and 1995, 1121 cases were examined over the video link. Apart from 156 normal cases all were discussed with surgeons, most at 96 weekly conferences but approximately 50 at conferences taking place as soon as possible after the examination. Assuming that an average of three doctors attended the conferences before the video link was available, this amounts to a saving of 3 x 8 h in travelling time per videoconference. The average salary was 300 SKr/h and train tickets cost a further 400 SKr per person. The cost of the ISDN connection was approximately 1800 SKr/conference. The net gain was thus about 6500 SKr per videoconference, without taking into account the work that could be done with the doctors still in Karlskrona after the conference.


Subject(s)
Angiography/methods , Cardiology Service, Hospital/organization & administration , Interprofessional Relations , Teleradiology , Humans , Sweden , Teleradiology/economics , Teleradiology/statistics & numerical data , Video Recording
16.
Phys Rev A ; 51(1): 179-184, 1995 Jan.
Article in English | MEDLINE | ID: mdl-9911570
17.
Pharm Res ; 11(5): 747-50, 1994 May.
Article in English | MEDLINE | ID: mdl-8058647

ABSTRACT

Serum levels of radioimmunoactive salmon calcitonin (sCT) were determined in 10 healthy volunteers after intranasal administration (IN) of 100-, 205-, and 450-IU of sCT with 0.5% sodium tauro-24,25-dihydrofusidate (STDHF), a 200-IU commercial IN formulation, and a 100-IU intramuscular (IM) formulation. Relative to the IM dose, the bioavailabilities of the IN formulations containing 0.5% STDHF were 3.9, 7.9, and 7.4%, respectively. The 200-IU commercial formulation resulted in serum levels above the limit of detection in only 5 of 10 patients, with an average bioavailability of 1.6%.


Subject(s)
Calcitonin/pharmacokinetics , Adjuvants, Pharmaceutic , Administration, Intranasal , Adult , Biological Availability , Calcitonin/administration & dosage , Calcitonin/blood , Female , Fusidic Acid/analogs & derivatives , Fusidic Acid/pharmacology , Humans , Male , Radioimmunoassay
SELECTION OF CITATIONS
SEARCH DETAIL
...